PRRS - Why can't I achieve long-term stability on my farm?
Its high survivability in the environment, a long infective period, limited cross-protection, strains with different pathogenicity, and lateral infections make stabilization difficult.
Page 7 of articles about vaccine
What can we expect from the new ASF vaccine developed in China?
This vaccine looks promising, but... are we going to see it in Europe?
Pirbright shows new Nipah vaccines create ‘impressive’ immune response
Two new potential vaccines against Nipah virus developed by the University of Parma generate a strong immune response in pigs, and could be the key to preventing this deadly, zoonotic disease.
Highly effective vaccine against ASFV
The gene-deleted HLJ/-18-7GD virus is a safe and effective vaccine against ASFV, and could play an important role in controlling the spread of ASFV.
Increasing Canada's preparedness for ASF with the University of Saskatchewan's VIDO-InterVac
International Vaccine Centre, VIDO-InterVac will commence work in January to develop and test vaccines and antivirals for ASF, seeking to protect the pork industry in Canada and worldwide.
Boehringer Ingelheim introduces DiaTEC purification technology for Ingelvac CircoFLEX®
Ingelvac CircoFLEX® was the first PCV2 vaccine that could be freshly mixed with an M hyo vaccine. With DiaTEC diafiltration technology, Ingelvac CircoFLEX® becomes the first and only non-virucidal PCV2 vaccine for improved capabilities to be freshly mixed on farm.
What you didn't know about live vaccines
In many articles we have explained the difference between killed, live, modified, and subunit vaccines... but this is something totally new.
Salmonella vaccine now available to UK and Irish pig producers
Pig producers in the UK and Ireland have a new means of defense in the fight against salmonella with the launch of a highly effective salmonella vaccine that has already been well-proven in Germany and Poland.
Acclimation strategies in gilts to control Mycoplasma hyopneumoniae: what strategies can we use?
Exposure methods: natural, intranasal, intra-tracheal, aerosol or vaccination.
Pirbright grants licence for new Foot-and-Mouth disease vaccine
Instead of traditional methods of vaccine development, using infectious virus as its basis, they synthetically created empty protein shells to imitate the protein coat that forms the strong outer layer of the virus.
Prevtec Microbia to be Acquired by Elanco
Deal supports development of Prevtec Microbia’s pipeline and product expansion
Ceva’s acquisition of IDT swine vaccines delivers early promise with salmonella vaccine go-ahead in several European countries
Ceva will launch Salmoporc in Austria, Belgium, Czech Republic, Denmark, Hungary, Ireland, Italy, Netherlands, Portugal, Romania, Slovak Republic, United Kingdom through the remainder of 2019.
Ceva completes acquisition of IDT veterinary business assets
IDT’s strong range of swine vaccines will strengthen Ceva’s rapidly growing presence in this segment.
Zoetis receives EU Commission approval for variation group on Suvaxyn PRRS MLV Vaccine
Reduction of the onset of immunity for fattening pigs, gilts and sows from 28 days to 21 days. Extension of the duration of immunity for gilts and sows from 16 weeks to 26 weeks.
Serotyping of Actinobacillus pleuropneumoniae field isolates by PCR
A newly produced PCR-based test can help assigning all known App serotypes, which can be used to select the most appropriate vaccine.
Pirbright and ViroVet join forces to develop African swine fever antivirals
Commercial vaccines have been estimated to be several years away, so the development of alternative control methods is of critical global importance.